Optimized immobilization of single chain variable fragment antibody onto non-toxic fluorescent nanoparticles for efficient preparation of a bioprobe
Source abstract
Abstract
Single-chain variable fragment antibody (scFv) is a small molecular weight antibody that can be used for both therapeutic and diagnostic purposes. To visualize the interaction with the target biomolecules, scFv must be labeled with fluorescent molecules. In this study, to achieve the efficient labeling of scFv, we developed scFv-fluorescent nanoparticle conjugates to utilize scFv as bioprobes. As fluorescent carriers, cadmium-free ZnS-AgInS2/ZnS core/shell nanoparticles were used, and scFv was immobilized onto the nanoparticles via the interaction of nickel ions on nitrilotriacetic acid and hexahistidine (His-tag) fused with scFv. UV-Vis, fluorescence spectra, NMR, and dynamic laser scattering were used to characterize the scFv immobilized fluorescent nanoparticles (scFv-FNPs). The amounts of scFv on FNPs were controlled by the concentration of scFv. The scFv-FNPs that were prepared were non-toxic and selectively bound to cancer cells. The scFv-FNPs could be used as bioanalytical tools, and the immobilization method described here is a promising method for labeling biomolecules with the His-tag.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Monoclonal and Polyclonal Antibodies Research · Advanced biosensing and bioanalysis techniques · Advanced Biosensing Techniques and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (32)
Show source-provided references
1. Direct conjugation of antibodies to the ZnS shell of quantum dots for FRET immunoassays with low picomolar detection limits10.1039/C6CC08835J ↗
2. Selective uptake into drug resistant mammalian cancer by cell penetrating peptide-mediated delivery10.1021/acs.bioconjchem.8b00429 ↗
3. Quantum dot monolayer for surface plasmon resonance signal enhancement and DNA hybridization detection10.1016/j.bios.2016.02.013 ↗
4. Cadmium-free sugar-chain-immobilized fluorescent nanoparticles containing low-toxicity ZnS-AgInS2 cores for probing lectin and cells10.1021/bc400425w ↗
5. Stable sugar-chain-immobilized fluorescent nanoparticles for probing lectin and cells10.1002/asia.201200362 ↗
6. Origin of dual photoluminescence states in ZnS–CuInS2 alloy nanostructures10.1021/acs.jpcc.6b01905 ↗
7. Aqueous synthesis of highly luminescent AgInS(2)-ZnS quantum dots and their biological applications10.1039/c3nr34159c ↗
8. InP quantum dots: synthesis and lighting applications10.1002/smll.202002454 ↗
9. Facile synthesis of ZnS− AgInS2 solid solution nanoparticles for a color-adjustable luminophore10.1021/ja0750470 ↗
10. Characterizing mixed phosphonic acid ligand capping on CdSe/ZnS quantum dots using ligand exchange and NMR spectroscopy10.1002/mrc.4372 ↗
11. Quenching of CdSe− ZnS Core− Shell quantum dot luminescence by water-soluble Thiolated ligands10.1021/jp075848p ↗
12. Improved biological activity of a single chain antibody fragment against human epidermal growth factor receptor 2 (HER2) expressed in the periplasm of Escherichia coli10.1016/j.pep.2015.07.005 ↗
13. A recombinant scFv antibody-based fusion protein that targets EGFR associated with IMPDH2 downregulation and its drug conjugate show therapeutic efficacy against esophageal cancer10.1080/10717544.2022.2063454 ↗
14. Development of a SARS-CoV-2-specific biosensor for antigen detection using scFv-Fc fusion proteins10.1016/j.bios.2020.112868 ↗
15. Immuno-PET imaging and pharmacokinetics of an Anti-CEA scFv-based trimerbody and its monomeric counterpart in human gastric carcinoma-bearing mice10.1021/acs.molpharmaceut.8b01006 ↗
16. Multimodal molecular imaging of atherosclerosis: nanoparticles functionalized with scFv fragments of an anti-alphaIIbbeta3 antibody
17. Affinity maturation of an TpoR targeting antibody in full-length IgG form for enhanced agonist activity10.1093/protein/gzy002 ↗
18. Near-infrared fluorescence imaging of EGFR-overexpressing tumors in the mouse xenograft model using scFv-IRDye800CW and cetuximab-IRDye800CW10.1155/2022/9589820 ↗
19. A 3E8.scFv.Cys-IR800 conjugate targeting TAG-72 in an orthotopic colorectal cancer model10.1007/s11307-017-1096-4 ↗
20. Sortase A-mediated site-specific labeling of camelid single-domain antibody-fragments: a versatile strategy for multiple molecular imaging modalities10.1002/cmmi.1696 ↗
21. Quantum dots in biomedical applications10.1016/j.actbio.2019.05.022 ↗
22. Cell profiling based on sugar-chain-cell binding interaction and its application to typing and quality verification of cells10.1002/cbic.201900028 ↗
23. Surface modification of stober silica nanoparticles with controlled moiety densities determines their cytotoxicity profiles in macrophages10.1021/acs.langmuir.9b02578 ↗
24. Development of sugar chain-binding single-chain variable fragment antibody to adult T-cell leukemia cells using glyco-nanotechnology and phage display method10.1093/jb/mvy005 ↗
25. Characterizing the surface coverage of protein-gold nanoparticle bioconjugates10.1021/acs.bioconjchem.8b00366 ↗
26. Human T-cell leukemia virus type I Tax induces expression of the Rel-related family of kappa B enhancer-binding proteins: evidence for a pretranslational component of regulation10.1128/jvi.65.12.6892-6899.1991 ↗
27. Identification of a bioactive compound against adult T-cell Leukaemia from bitter gourd seeds10.3390/plants3010018 ↗
28. A retrovirus from human leukemia cell lines: its isolation, characterization, and implication in human adult T-cell leukemia (ATL)
29. Apoptosis inducing bivalent single-chain antibody fragments against CD47 showed antitumor potency for multiple myeloma10.1016/j.leukres.2004.09.005 ↗
30. Physicochemical properties and cellular toxicity of nanocrystal quantum dots depend on their surface modification10.1021/nl048715d ↗
31. Polyvalent display and packing of peptides and proteins on semiconductor quantum dots: predicted versus experimental results10.1002/smll.200901845 ↗
32. How antibody surface coverage on nanoparticles determines the activity and kinetics of antigen capturing for biosensing10.1021/ac501536z ↗